1. Home
  2. CION vs NPCE Comparison

CION vs NPCE Comparison

Compare CION & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CION

CION Investment Corporation

HOLD

Current Price

$6.71

Market Cap

464.0M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$13.01

Market Cap

485.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CION
NPCE
Founded
2011
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
464.0M
485.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
CION
NPCE
Price
$6.71
$13.01
Analyst Decision
Sell
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$18.33
AVG Volume (30 Days)
707.1K
196.8K
Earning Date
03-12-2026
03-03-2026
Dividend Yield
17.75%
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
$17.55
N/A
Revenue Growth
N/A
25.13
52 Week Low
$6.50
$7.56
52 Week High
$11.07
$18.97

Technical Indicators

Market Signals
Indicator
CION
NPCE
Relative Strength Index (RSI) 19.83 32.96
Support Level N/A $12.47
Resistance Level $10.30 $13.81
Average True Range (ATR) 0.24 0.85
MACD -0.07 -0.06
Stochastic Oscillator 11.22 14.56

Price Performance

Historical Comparison
CION
NPCE

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: